AMAG Pharmaceuticals, Inc. Provides Business Outlook For 2014 And Reports 2013 Financial Results

WALTHAM, Mass., Feb. 6, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2013. The company achieved record annual U.S. Feraheme® net product sales of $71.4 million. As of December 31, 2013, the company's cash and investments totaled $216.7 million (including $2.9 million of restricted cash).

Help employers find you! Check out all the jobs and post your resume.